Abstract
Full text available
Current Drug Targets
Title: Aiming at New Targets for the Treatment of Affective Disorders: An Introduction
Volume: 10 Issue: 11
Author(s): Eliyahu Dremencov
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
Dremencov Eliyahu, Aiming at New Targets for the Treatment of Affective Disorders: An Introduction, Current Drug Targets 2009; 10 (11) . https://dx.doi.org/10.2174/138945009789735110
DOI https://dx.doi.org/10.2174/138945009789735110 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Caffeine; the Forgotten Potential for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Erythrocyte Amyloid Beta Peptide Isoform Distributions in Alzheimer and Mild Cognitive Impairment
Current Alzheimer Research Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors
Current Pharmaceutical Design Gene Therapy for Osteoinduction
Current Gene Therapy Neuroproteomics and the Detection of Regulatory Phosphosites
Current Proteomics Understanding the Basis for the Association of apoE4 with Alzheimers Disease: Opening the Door for Therapeutic Approaches
Current Alzheimer Research MicroRNA Pathways: An Emerging Role in Identification of Therapeutic Strategies
Current Gene Therapy Beyond Cholinesterase Inhibition: Anti-Inflammatory Role and Pharmacological Profile of Current Drug Therapy for Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Metabolomics of Serum Peptides
Protein & Peptide Letters Neuronal Nicotinic Acetylcholine Receptor Agonists: Pharmacophores, Evolutionary QSAR and 3D-QSAR models
Current Topics in Medicinal Chemistry Internet Addiction: A Systematic Review of Epidemiological Research for the Last Decade
Current Pharmaceutical Design Adenosine A2A-D2 Receptor-Receptor Interactions in Putative Heteromers in the Regulation of the Striato-Pallidal GABA Pathway: Possible Relevance for Parkinson`s Disease and its Treatment
Current Protein & Peptide Science Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure- Activity Relationships of a Neuroprotective Peptide
Current Medicinal Chemistry Are Descending Control Pathways of the Lower Urinary Tract and Pain Overlapping Systems?
Central Nervous System Agents in Medicinal Chemistry The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease
Current Pharmaceutical Design Oncogenic Signalling Networks and Polypharmacology as Paradigms to Cope with Cancer Heterogeneity
Current Proteomics Applications of Indan-1,3-Dione in Heterocyclic Synthesis
Current Organic Synthesis Dermatologic Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Piper sarmentosum Roxb. Root Extracts Confer Neuroprotection by Attenuating Beta Amyloid-Induced Pro-Inflammatory Cytokines Released from Microglial Cells
Current Alzheimer Research Monitoring of Treatment-Induced Apoptosis in Oncology with PET and SPECT
Current Pharmaceutical Design